Go Pro
→ The dollar reset no one told you about (From Porter & Company) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Artivion, Inc. stock logo
AORT
Artivion
$24.88
-0.8%		$26.27
$19.16
▼
$48.25
$1.21B1.25596,542 shs168,380 shs
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
$14.52
+0.6%		$13.55
$3.43
▼
$15.17
$1.32B1.2595,024 shs236,279 shs
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
$15.62
+0.8%		$17.59
$8.70
▼
$20.49
$1.22B1.21867,882 shs291,479 shs
Mobia Medical, Inc. stock logo
MOBI
Mobia Medical
$10.18
+1.7%		$11.58
$9.88
▼
$15.29
$338.89MN/A151,616 shs43,834 shs
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Artivion, Inc. stock logo
AORT
Artivion
0.00%-1.81%-14.00%+19.77%-38.23%
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
0.00%-3.99%+1.26%+49.22%+278.74%
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
0.00%-7.30%-15.49%-11.23%+2.92%
Mobia Medical, Inc. stock logo
MOBI
Mobia Medical
0.00%-13.93%-14.88%-9.08%+1,000,999,900.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Artivion, Inc. stock logo
AORT
Artivion
$24.88
-0.8%		$26.27
$19.16
▼
$48.25
$1.21B1.25596,542 shs168,380 shs
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
$14.52
+0.6%		$13.55
$3.43
▼
$15.17
$1.32B1.2595,024 shs236,279 shs
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
$15.62
+0.8%		$17.59
$8.70
▼
$20.49
$1.22B1.21867,882 shs291,479 shs
Mobia Medical, Inc. stock logo
MOBI
Mobia Medical
$10.18
+1.7%		$11.58
$9.88
▼
$15.29
$338.89MN/A151,616 shs43,834 shs
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Artivion, Inc. stock logo
AORT
Artivion
0.00%-1.81%-14.00%+19.77%-38.23%
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
0.00%-3.99%+1.26%+49.22%+278.74%
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
0.00%-7.30%-15.49%-11.23%+2.92%
Mobia Medical, Inc. stock logo
MOBI
Mobia Medical
0.00%-13.93%-14.88%-9.08%+1,000,999,900.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Artivion, Inc. stock logo
AORT
Artivion
2.75
Moderate Buy$44.8380.23% Upside
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
2.38
Hold$15.406.10% Upside
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
1.88
Reduce$18.8620.72% Upside
Mobia Medical, Inc. stock logo
MOBI
Mobia Medical
2.57
Moderate Buy$20.75103.83% Upside

Current Analyst Ratings Breakdown

Latest MOBI, DRTS, AORT, and IART Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/3/2026
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$17.00 ➝ $30.00
9/1/2026
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold ➝ Strong Sell
8/18/2026
Artivion, Inc. stock logo
AORT
Artivion
Canaccord Genuity Group Inc. logo
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$39.00 ➝ $40.00
8/14/2026
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
8/12/2026
Mobia Medical, Inc. stock logo
MOBI
Mobia Medical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageSell (E-)
8/12/2026
Mobia Medical, Inc. stock logo
MOBI
Mobia Medical
JPMorgan Chase & Co. logo
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$15.00 ➝ $17.00
8/12/2026
Mobia Medical, Inc. stock logo
MOBI
Mobia Medical
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$19.00
8/11/2026
Artivion, Inc. stock logo
AORT
Artivion
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D+) ➝ Sell (D-)
8/11/2026
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$15.00 ➝ $16.00
8/7/2026
Artivion, Inc. stock logo
AORT
Artivion
Canaccord Genuity Group Inc. logo
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$39.00
8/3/2026
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong Sell ➝ Hold
(Data available from 9/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Artivion, Inc. stock logo
AORT
Artivion
$441.33M2.75$1.09 per share22.76$9.46 per share2.63
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
N/AN/AN/AN/A$0.88 per shareN/A
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
$1.64B0.74$4.26 per share3.67$13.40 per share1.17
Mobia Medical, Inc. stock logo
MOBI
Mobia Medical
$32.04M10.58N/AN/AN/A∞
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Artivion, Inc. stock logo
AORT
Artivion
$9.77M-$0.07N/A32.31N/A-0.67%6.07%2.93%11/5/2026 (Estimated)
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
-$42.63M-$1.04N/AN/AN/AN/A-138.12%-81.68%11/19/2026 (Estimated)
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
-$516.47M-$0.09N/A6.080.80-0.44%18.30%5.30%10/29/2026 (Estimated)
Mobia Medical, Inc. stock logo
MOBI
Mobia Medical
-$46.50M-$20.18N/AN/AN/AN/AN/AN/AN/A

Latest MOBI, DRTS, AORT, and IART Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/11/2026Q2 2026
Mobia Medical, Inc. stock logo
MOBI
Mobia Medical
-$0.83-$1.10-$0.27-$1.10N/A$13.51 million
8/10/2026Q2 2026
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
-$0.1409-$0.50-$0.3591-$0.50$0.14 millionN/A
8/6/2026Q2 2026
Artivion, Inc. stock logo
AORT
Artivion
$0.0025$0.13+$0.1275-$0.28$119.99 million$125.76 million
7/29/2026Q2 2026
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
$0.4805$0.56+$0.0795$0.06$417.54 million$418.76 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Artivion, Inc. stock logo
AORT
Artivion
N/AN/AN/AN/AN/A
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
N/AN/AN/AN/AN/A
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
N/AN/AN/AN/AN/A
Mobia Medical, Inc. stock logo
MOBI
Mobia Medical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Artivion, Inc. stock logo
AORT
Artivion
0.82
3.47
2.51
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
0.15
11.09
7.79
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
1.75
3.60
2.11
Mobia Medical, Inc. stock logo
MOBI
Mobia Medical
0.04
13.28
12.80

Institutional Ownership

CompanyInstitutional Ownership
Artivion, Inc. stock logo
AORT
Artivion
86.37%
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
2.65%
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
84.78%
Mobia Medical, Inc. stock logo
MOBI
Mobia Medical
N/A

Insider Ownership

CompanyInsider Ownership
Artivion, Inc. stock logo
AORT
Artivion
6.30%
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
39.50%
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
3.84%
Mobia Medical, Inc. stock logo
MOBI
Mobia Medical
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Artivion, Inc. stock logo
AORT
Artivion
1,80048.76 million45.68 millionOptionable
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
12190.33 million54.65 millionNo Data
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
4,42777.77 million74.79 millionOptionable
Mobia Medical, Inc. stock logo
MOBI
Mobia Medical
16733.29 millionN/AN/A

Recent News About These Companies

Mobia Medical, Inc. (NASDAQ:MOBI) Given Consensus Recommendation of "Moderate Buy" by Brokerages
September 10, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/consensus-mobia-medical-inc-nasdaq-mobi-given-consensus-recommendation-of-moderate-buy-by-brokerages-2026-09-10/
Mobia Medical Announces Paired VNS Added To Updated AHA Stroke Recovery Guidelines
August 28, 2026  |  rttnews.comhttps://www.rttnews.com/3686348/mobia-medical-announces-paired-vns-added-to-updated-aha-stroke-recovery-guidelines.aspx
Mobia Medical Announces Addition of Paired VNS to Updated AHA Stroke Guidelines
August 28, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/28/3352638/0/en/mobia-medical-announces-addition-of-paired-vns-to-updated-aha-stroke-guidelines.html
Insider Buying: Mobia Medical (NASDAQ:MOBI) Director Buys $198,442.87 in Stock
August 21, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-mobi-insider-buying-and-selling-2026-08-21/
Mobia Medical (NASDAQ:MOBI) Director Buys 16,441 Shares
August 20, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/mobia-medical-nasdaqmobi-director-buys-16441-shares-2026-08-20/
Mobia Medical (MOBI) Q2 2026 Earnings Call Transcript
August 18, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/mobia-medical-mobi-q2-2026-233128688.html
Casey Tansey Acquires 35,572 Shares of Mobia Medical (NASDAQ:MOBI) Stock
August 18, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/casey-tansey-acquires-35572-shares-of-mobia-medical-nasdaqmobi-stock-2026-08-18/
Mobia Medical (NASDAQ:MOBI) Director Purchases 15,821 Shares
August 18, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-mobi-insider-buying-and-selling-2026-08-18/
Insider Buying: Mobia Medical (NASDAQ:MOBI) Director Acquires $184,472.86 in Stock
August 17, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-buying-mobia-medical-nasdaqmobi-director-acquires-18447286-in-stock-2026-08-17/
Insider Buying: Mobia Medical (NASDAQ:MOBI) Director Purchases 17,166 Shares of Stock
August 17, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-buying-mobia-medical-nasdaqmobi-director-purchases-17166-shares-of-stock-2026-08-17/
Mobia Medical Signals Fast Growth in Earnings Call
August 16, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/mobia-medical-signals-fast-growth-in-earnings-call?utm_source=marketbeat.com&utm_medium=referral
Mobia Medical, Inc. (NASDAQ:MOBI) Given Average Recommendation of "Moderate Buy" by Analysts
August 16, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/mobia-medical-inc-nasdaqmobi-given-average-recommendation-of-moderate-buy-by-analysts-2026-08-16/
Mobia Medical, Inc.: Mobia Medical Reports Second Quarter 2026 Financial Results
August 12, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-08/69283103-mobia-medical-inc-mobia-medical-reports-second-quarter-2026-financial-results-399.htm
Mobia Medical Inc (MOBI) (Q2 2026) Earnings Call Highlights: Revenue Surges 102% as IPO Fuels ...
August 12, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/mobia-medical-inc-mobi-q2-050126433.html
Mobia Medical forecasts $54M-$56M 2026 revenue, citing 69%-75% growth target
August 11, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4631165-mobia-medical-forecasts-54m-56m-2026-revenue-citing-69-percentminus-75-percent-growth-target
Mobia Medical, Inc. (MOBI) Q2 2026 Earnings Call Transcript
August 11, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4935024-mobia-medical-inc-mobi-q2-2026-earnings-call-transcript
Mobia Medical: Q2 Earnings Snapshot
August 11, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/mobia-medical-q2-earnings-snapshot-204207592.html
Mobia Medical Reports Second Quarter 2026 Financial Results
August 11, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/11/3343160/0/en/mobia-medical-reports-second-quarter-2026-financial-results.html
Mobia Medical Appoints Myriam Curet, M.D., to its Board of Directors
August 3, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/mobia-medical-appoints-myriam-curet-m-d-to-its-board-of-directors-1036402048
Mobia Medical to Report Second Quarter 2026 Financial Results on August 11, 2026
July 21, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/21/3330947/0/en/mobia-medical-to-report-second-quarter-2026-financial-results-on-august-11-2026.html
Mobia Medical Inc (MOBI)
July 15, 2026  |  investing.comhttps://www.investing.com/equities/mobia-medical-cash-flow

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
A gold futuristic electric concept car parked on a street with a city skyline and capitol dome at dusk.
Tesla's Cybercab Launch Could Reshape Margins for Uber and Lyft
By Jeffrey Neal Johnson | August 19, 2026
Large oil tanker ship departing a port terminal with storage tanks and cranes visible near the water.
Striking Oil: How the U.S. Play for Venezuela Fuels Supermajors
By Jeffrey Neal Johnson | September 2, 2026
AST SpaceMobile logo displayed on a smartphone screen with a satellite panel and city skyline in background.
AST SpaceMobile Is Down 54%—Can FCC Progress and BlueBirds Reverse the Slide?
By Jessica Mitacek | August 31, 2026
Composite image of a rocket launching from a tower with flames and smoke, Earth's curvature visible in the background.
3 Space Stocks: Ready for Liftoff or Burning Up on Reentry?
By Thomas Hughes | September 1, 2026
EHang logo overlaid on an autonomous aerial vehicle parked on a rooftop helipad with a city skyline background.
Boarding Call: EHang Secures First-Mover Altitude
By Jeffrey Neal Johnson | September 1, 2026
Artivion stock logo

Artivion NYSE:AORT

$24.88 -0.21 (-0.82%)
As of 02:12 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company provides BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and aortic arch stent grafts including E-vita Open Plus and E-vita Open Neo. It offers E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, a stent graft system for the treatment of infrarenal abdominal aortic aneurysms. In addition, the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products for angina treatment; CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as pyrolytic carbon coating services to medical device manufacturers. It serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022. Artivion, Inc. was incorporated in 1984 and is headquartered in Kennesaw, Georgia.

Alpha Tau Medical stock logo

Alpha Tau Medical NASDAQ:DRTS

$14.52 +0.09 (+0.59%)
As of 02:12 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.

Integra LifeSciences stock logo

Integra LifeSciences NASDAQ:IART

$15.62 +0.12 (+0.77%)
As of 02:12 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Mobia Medical stock logo

Mobia Medical NASDAQ:MOBI

$10.18 +0.17 (+1.70%)
As of 01:54 PM Eastern

Mobia Medical Inc. is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. Mobia Medical Inc. is based in AUSTIN, Texas.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas